BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 29687288)

  • 1. Increased serum levels of adhesion molecules ICAM-1 and VCAM-1 in systemic sclerosis are not specific for pulmonary manifestations.
    Thakkar V; Patterson KA; Stevens W; Wilson M; Roddy J; Sahhar J; Proudman S; Hissaria P; Nikpour M
    Clin Rheumatol; 2018 Jun; 37(6):1563-1571. PubMed ID: 29687288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serial circulating adhesion molecule levels reflect disease severity in systemic sclerosis.
    Denton CP; Bickerstaff MC; Shiwen X; Carulli MT; Haskard DO; Dubois RM; Black CM
    Br J Rheumatol; 1995 Nov; 34(11):1048-54. PubMed ID: 8542206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of asymmetric dimethylarginine alone and in combination with N-terminal pro-B-type natriuretic peptide as a screening biomarker for systemic sclerosis-related pulmonary arterial hypertension: a case control study.
    Thakkar V; Stevens W; Prior D; Rabusa C; Sahhar J; Walker JG; Roddy J; Lester S; Rischmueller M; Zochling J; Nash P; Gabbay E; Youssef P; Proudman SM; Nikpour M
    Clin Exp Rheumatol; 2016; 34 Suppl 100(5):129-136. PubMed ID: 27214686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating levels of ICAM-1, VCAM-1, and MCP-1 are increased in haemodialysis patients: association with inflammation, dyslipidaemia, and vascular events.
    Papayianni A; Alexopoulos E; Giamalis P; Gionanlis L; Belechri AM; Koukoudis P; Memmos D
    Nephrol Dial Transplant; 2002 Mar; 17(3):435-41. PubMed ID: 11865089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bosentan regulates the expression of adhesion molecules on circulating T cells and serum soluble adhesion molecules in systemic sclerosis-associated pulmonary arterial hypertension.
    Iannone F; Riccardi MT; Guiducci S; Bizzoca R; Cinelli M; Matucci-Cerinic M; Lapadula G
    Ann Rheum Dis; 2008 Aug; 67(8):1121-6. PubMed ID: 18029384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1) and E-selectin in urological malignancies.
    Perabo F; Sharma S; Gierer R; Wirger A; Fimmers R; Steiner G; Adam M; Schultze-Seemann W
    Indian J Cancer; 2001 Mar; 38(1):1-7. PubMed ID: 14758878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nailfold capillaroscopic changes in patients with idiopathic pulmonary arterial hypertension and systemic sclerosis-related pulmonary arterial hypertension.
    Corrado A; Correale M; Mansueto N; Monaco I; Carriero A; Mele A; Colia R; Di Biase M; Cantatore FP
    Microvasc Res; 2017 Nov; 114():46-51. PubMed ID: 28619664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levels of soluble adhesion molecules in various clinical presentations of coronary atherosclerosis.
    Güray U; Erbay AR; Güray Y; Yilmaz MB; Boyaci AA; Sasmaz H; Korkmaz S; Kütük E
    Int J Cardiol; 2004 Aug; 96(2):235-40. PubMed ID: 15262039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma ICAM-1 and VCAM-1 levels in type 2 diabetic patients with and without microalbuminuria.
    Bruno CM; Valenti M; Bertino G; Ardiri A; Bruno F; Cunsolo M; Pulvirenti D; Neri S
    Minerva Med; 2008 Feb; 99(1):1-5. PubMed ID: 18299691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased plasma soluble adhesion molecules; ICAM-1, VCAM-1, and E-selectin levels in patients with slow coronary flow.
    Turhan H; Saydam GS; Erbay AR; Ayaz S; Yasar AS; Aksoy Y; Basar N; Yetkin E
    Int J Cardiol; 2006 Apr; 108(2):224-30. PubMed ID: 16002164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percutaneous transluminal mitral valvuloplasty reduces circulating vascular cell adhesion molecule-1 in rheumatic mitral stenosis.
    Chen MC; Chang HW; Juang SS; Yip HK; Wu CJ; Yu TH; Cheng CI
    Chest; 2004 Apr; 125(4):1213-7. PubMed ID: 15078727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interstitial lung disease increases mortality in systemic sclerosis patients with pulmonary arterial hypertension without affecting hemodynamics and exercise capacity.
    Michelfelder M; Becker M; Riedlinger A; Siegert E; Drömann D; Yu X; Petersen F; Riemekasten G
    Clin Rheumatol; 2017 Feb; 36(2):381-390. PubMed ID: 28028682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiogenic and inflammatory biomarkers for screening and follow-up in patients with pulmonary arterial hypertension.
    Kylhammar D; Hesselstrand R; Nielsen S; Scheele C; Rådegran G
    Scand J Rheumatol; 2018 Jul; 47(4):319-324. PubMed ID: 29528272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble CD90 as a potential marker of pulmonary involvement in systemic sclerosis.
    Kollert F; Christoph S; Probst C; Budweiser S; Bannert B; Binder M; Sehnert B; Voll RE; Warnatz K; Zissel G; Walker UA; Prasse A; Saalbach A
    Arthritis Care Res (Hoboken); 2013 Feb; 65(2):281-7. PubMed ID: 22807289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The proadhesive phenotype of systemic sclerosis skin promotes myeloid cell adhesion via ICAM-1 and VCAM-1.
    Rabquer BJ; Hou Y; Del Galdo F; Kenneth Haines G; Gerber ML; Jimenez SA; Seibold JR; Koch AE
    Rheumatology (Oxford); 2009 Jul; 48(7):734-40. PubMed ID: 19439502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased levels of circulating adhesion molecules in neonates with congenital diaphragmatic hernia complicated by persistent pulmonary hypertension.
    Kobayashi H; Yamataka A; Okazaki T; Lane GJ; Puri P; Miyano T
    Pediatr Surg Int; 2004 Jan; 20(1):19-23. PubMed ID: 14673614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants of impairment in lung diffusing capacity in patients with systemic sclerosis.
    Guarnieri G; Zanatta E; Mason P; Scarpa MC; Pigatto E; Maestrelli P; Cozzi F
    Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S80-6. PubMed ID: 25897784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum P-selectin, soluble vascular cell adhesion molecule-I (s-VCAM-I) and soluble intercellular adhesion molecule-I (s-ICAM-I) levels in bladder carcinoma patients with different stages.
    Coskun U; Sancak B; Sen I; Bukan N; Tufan MA; Gülbahar O; Sozen S
    Int Immunopharmacol; 2006 Apr; 6(4):672-7. PubMed ID: 16504931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic and prognostic values of adhesion molecules VCAM-1, ICAM-1 and C-reactive protein in Egyptian patients with chronic kidney disease.
    Attalah MF; Adel LA; Fahmy DE
    Egypt J Immunol; 2011; 18(2):59-66. PubMed ID: 23082471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of soluble adhesion molecules CD44 (CD44st, CD44v5, CD44v6), ICAM-1, and VCAM-1 as tumor markers in head and neck cancer.
    Kawano T; Yanoma S; Nakamura Y; Shiono O; Kokatu T; Kubota A; Furukawa M; Tsukuda M
    Am J Otolaryngol; 2005; 26(5):308-13. PubMed ID: 16137528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.